Effectiveness of a Socio-Community Health Intervention on Pre-Frailty in Older Adults

Launched by KERALTY SAS. COLOMBIA · Oct 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a special health program aimed at helping older adults who are at risk of becoming frail, which means they may have difficulty with daily activities and overall health. The goal is to see if this program, which focuses on community support and health improvements, can make a difference in their strength, emotional well-being, and social connections over time. Researchers will look at how participants feel and function after 3 and 6 months of being part of the program, as well as track any hospital visits or stays in care facilities.

To participate, individuals must be at least 60 years old and considered pre-frail based on their recent health records. They should be able to stay in Bogotá, D.C., during the study. However, those who are already receiving care from community health programs, have certain medical conditions, or have had serious falls or illnesses recently might not be eligible. If you or a loved one fit the criteria, this study could provide an opportunity to engage in a supportive program while contributing to valuable research on improving health for older adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals ≥ 60 years old classified as pre-frail in the last 3 months and documented in their medical history.
• • Individuals who meet the requirements and provide voluntary informed consent for their participation.
• • Individuals available to remain in Bogotá D.C. during the study period.
• Exclusion Criteria:
• • Individuals receiving care at community-focused medical centers.
• • Individuals attending community dining programs, physical activity programs, community groups, care blocks, volunteering, or other related activities.
• • Individuals who have experienced falls in the last 6 months with clinical consequences (hospitalization, fractures, traumatic brain injury).
• • Individuals with a clinical history of moderate cognitive impairment, neurodegenerative diseases (e.g., Parkinson's disease), and/or neuro-musculoskeletal disorders, active cancer, end-stage renal disease, unstable ischemic heart disease, uncontrolled arrhythmias, severe aortic stenosis, uncontrolled hypertension (\>180/100 mmHg), or advanced heart failure, exacerbation of chronic diseases (COPD, heart failure), unrehabilitated severe hearing loss, deafness, or blindness with communication limitations.
• • Acute conditions requiring hospitalization, such as acute myocardial infarction or urinary tract infections.
• • Bone fractures in the last 3 months.
• • Individuals unable to follow instructions or with behavioral changes that hinder their participation in the study.
• • Individuals with severe psychiatric illness that, in the physician's judgment, prevents proper adherence to the study intervention.
• • Institutionalized individuals in long-term care facilities.